Riociguat: Clinical research and evolving role in therapy

This review evaluates the results of the original clinical trials of riociguat for the treatment of pulmonary hypertension (PH) and chronic thromboembolic PH, and summarises the body of work that has examined safety and efficacy for the treatment of other types of PH.

British Journal of Clinical Pharmacology